Get the Stockscreener App
1.58
8.67%
-0.15
After Hours:
1.61
0.03
+1.90%
Pulmonx Corp stock is traded at $1.58, with a volume of 327.04K.
It is down -8.67% in the last 24 hours and down -1.86% over the past month.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$1.73
Open:
$1.7
24h Volume:
327.04K
Relative Volume:
0.53
Market Cap:
$64.38M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-0.9875
EPS:
-1.6
Net Cash Flow:
$-38.42M
1W Performance:
-14.13%
1M Performance:
-1.86%
6M Performance:
-69.67%
1Y Performance:
-75.50%
1-Day Range:
$1.55
$1.73
1-Week Range:
$1.55
$1.92
52-Week Range:
$1.47
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Name
Pulmonx Corp
Sector
Industry
Phone
650-364-0400
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.58 | 70.49M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-10-25 | Initiated | D. Boral Capital | Buy |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-04-24 | Initiated | Lake Street | Buy |
| Feb-23-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-05-23 | Initiated | Craig Hallum | Buy |
| Feb-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Neutral |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-20 | Initiated | BofA Securities | Buy |
| Oct-26-20 | Initiated | Canaccord Genuity | Buy |
| Oct-26-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-26-20 | Initiated | Stifel | Buy |
| Oct-26-20 | Initiated | Wells Fargo | Equal Weight |
View All
Pulmonx Corp Stock (LUNG) Latest News
Market reaction to Pulmonx Corporation’s recent newsJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Pulmonx (NASDAQ:LUNG) - MarketBeat
Why Pulmonx Corporation stock attracts high net worth investorsPortfolio Growth Summary & Community Verified Trade Signals - newser.com
Heatmap analysis for Pulmonx Corporation and competitorsInflation Watch & Verified Stock Trade Ideas - newser.com
Can Pulmonx Corporation rally from current levelsPrice Action & Real-Time Volume Trigger Notifications - newser.com
Wall Street Zen Downgrades Pulmonx (NASDAQ:LUNG) to Sell - Defense World
Pulmonx (NASDAQ:LUNG) Cut to "Sell" at Wall Street Zen - MarketBeat
Will Pulmonx Corporation benefit from macro trendsWeekly Profit Report & Community Trade Idea Sharing - newser.com
Will Pulmonx Corporation stock go up soonJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Does Pulmonx Corporation show high probability of rebound2025 Momentum Check & Real-Time Market Trend Scan - newser.com
What machine learning models say about Pulmonx CorporationJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Goldman Sachs Group Inc. Has $1.32 Million Holdings in Pulmonx Corporation $LUNG - Defense World
How high can Pulmonx Corporation stock goQuarterly Trade Review & Technical Pattern Based Buy Signals - newser.com
Pulmonx Corporation stock daily chart insights2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Tools to assess Pulmonx Corporation’s risk profile2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
How to recover losses in Pulmonx Corporation stock2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
What earnings revisions data tells us about Pulmonx CorporationJuly 2025 Summary & Daily Price Action Insights - newser.com
How to interpret RSI for Pulmonx Corporation stockEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Investment Review: What is the target price for Pulmonx Corporation stock2025 Macro Impact & Weekly Return Optimization Alerts - خودرو بانک
Will earnings trigger a reversal in Pulmonx CorporationTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Pulmonx Corporation stock trend forecastQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
Forecasting Pulmonx Corporation price range with options dataMarket Trend Summary & High Accuracy Swing Trade Signals - newser.com
Live market analysis of Pulmonx Corporation2025 Key Highlights & Weekly Setup with ROI Potential - newser.com
Insider Trends: Is Pulmonx Corporation stock forming a cup and handleDip Buying & Capital Efficiency Focused Strategies - khodrobank.com
Investor Mood: What’s the RSI of Pulmonx Corporation stock2025 Market Overview & Community Trade Idea Sharing - خودرو بانک
Sentiment analysis tools applied to Pulmonx CorporationPortfolio Return Summary & Low Drawdown Momentum Ideas - newser.com
Combining price and volume data for Pulmonx CorporationPortfolio Performance Report & Fast Entry High Yield Tips - newser.com
Is Pulmonx Corporation building a consolidation baseIndex Update & Weekly High Return Stock Forecasts - newser.com
What MACD signals say about Pulmonx CorporationGold Moves & Breakout Confirmation Trade Signals - newser.com
Pulmonx Corp Stock (LUNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pulmonx Corp Stock (LUNG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Joshi Mehul | Chief Financial Officer & PAO |
Sep 02 '25 |
Sale |
1.60 |
7,936 |
12,698 |
208,489 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Sep 02 '25 |
Sale |
1.60 |
6,543 |
10,469 |
379,788 |
| Lehman David Aaron | GENERAL COUNSEL |
Sep 02 '25 |
Sale |
1.60 |
9,769 |
15,630 |
263,270 |
| Ferrari Richard | Director |
Jun 12 '25 |
Sale |
3.16 |
8,000 |
25,280 |
87,024 |
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):